MD2231C2 - Composition for treatment of oncologic pathologies - Google Patents

Composition for treatment of oncologic pathologies

Info

Publication number
MD2231C2
MD2231C2 MDA20030069A MD20030069A MD2231C2 MD 2231 C2 MD2231 C2 MD 2231C2 MD A20030069 A MDA20030069 A MD A20030069A MD 20030069 A MD20030069 A MD 20030069A MD 2231 C2 MD2231 C2 MD 2231C2
Authority
MD
Moldova
Prior art keywords
treatment
composition
oil
oncologic
pathologies
Prior art date
Application number
MDA20030069A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD2231B1 (en
Inventor
Ион КАЛМЫК
Original Assignee
Ион КАЛМЫК
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ион КАЛМЫК filed Critical Ион КАЛМЫК
Priority to MDA20030069A priority Critical patent/MD2231C2/en
Publication of MD2231B1 publication Critical patent/MD2231B1/en
Publication of MD2231C2 publication Critical patent/MD2231C2/en

Links

Landscapes

  • Edible Oils And Fats (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention refers to medicine, in particular to oncology.Summary of the invention consists in that it is proposed a composition containing amaranthine oil and vegetable oil, which additionally contains 58…62% of ethyl alcohol, and in the capacity of vegetable oil is used refined sunflower oil, in the following ratio, % vol.:
MDA20030069A 2003-03-05 2003-03-05 Composition for treatment of oncologic pathologies MD2231C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030069A MD2231C2 (en) 2003-03-05 2003-03-05 Composition for treatment of oncologic pathologies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030069A MD2231C2 (en) 2003-03-05 2003-03-05 Composition for treatment of oncologic pathologies

Publications (2)

Publication Number Publication Date
MD2231B1 MD2231B1 (en) 2003-08-31
MD2231C2 true MD2231C2 (en) 2004-02-29

Family

ID=29268042

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030069A MD2231C2 (en) 2003-03-05 2003-03-05 Composition for treatment of oncologic pathologies

Country Status (1)

Country Link
MD (1) MD2231C2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU92007650A (en) * 1992-11-10 1995-02-10 Товарищество с ограниченной ответственностью - Компания "Стэр", Лтд. ANTI-TUMOR MEDICINE
RU2067451C1 (en) * 1993-01-22 1996-10-10 Научно-исследовательский институт фармакологии Томского научного центра РАМН Method of preparing agent showing antitumor action
WO1998024795A1 (en) * 1996-12-05 1998-06-11 Song Bae Kim Novel triterpene glycoside compound, process for preparation thereof and anti-cancer composition containing the same
RU2201759C2 (en) * 1998-11-03 2003-04-10 Сонг-Бае КИМ Pharmaceutical composition of antitumor activity (versions) and method for its obtaining (versions)
RU2204405C1 (en) * 2002-01-28 2003-05-20 Берников Владимир Яковлевич Agent eliciting adaptogenic activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033858A1 (en) * 1998-12-07 2000-06-15 Ecosmart Technologies, Inc. Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
RU2201246C2 (en) * 2001-02-28 2003-03-27 Малеева Галина Лаврентьевна Agent for treatment of oncological patient in postoperative period

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU92007650A (en) * 1992-11-10 1995-02-10 Товарищество с ограниченной ответственностью - Компания "Стэр", Лтд. ANTI-TUMOR MEDICINE
RU2067451C1 (en) * 1993-01-22 1996-10-10 Научно-исследовательский институт фармакологии Томского научного центра РАМН Method of preparing agent showing antitumor action
WO1998024795A1 (en) * 1996-12-05 1998-06-11 Song Bae Kim Novel triterpene glycoside compound, process for preparation thereof and anti-cancer composition containing the same
RU2201759C2 (en) * 1998-11-03 2003-04-10 Сонг-Бае КИМ Pharmaceutical composition of antitumor activity (versions) and method for its obtaining (versions)
RU2001115133A (en) * 1998-12-07 2003-05-20 Экосмарт Текнолоджиз, Инк. Composition for the treatment of cancer and method of using natural vegetable oils
RU2001105757A (en) * 2001-02-28 2002-12-27 Галина Лаврентьевна Малеева MEANS FOR TREATMENT OF ONCOLOGICAL DISEASES
RU2204405C1 (en) * 2002-01-28 2003-05-20 Берников Владимир Яковлевич Agent eliciting adaptogenic activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Амарантовое масло, regăsit în Internet: < URL: http:/user.cityline.ru/- *

Also Published As

Publication number Publication date
MD2231B1 (en) 2003-08-31

Similar Documents

Publication Publication Date Title
ATE292460T1 (en) COMPOSITIONS CONTAINING ACTIVE STILBENOID COMPOUNDS FOR LOWERING TRIGLYCERIDE LEVELS
TW200628076A (en) High PUFA oil compositions
TW200513193A (en) Fat or oil composition
SG155189A1 (en) Novel fenofibrate formulations and related methods of treatment
EG25613A (en) Thienopyrimidinediones and their use in the modulation of autoimmune disease
TW200420288A (en) Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person
EP1673078A4 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer&#39;s disease
AP2002002426A0 (en) Ppar agonists
EA200601841A1 (en) COMPOSITIONS CONTAINING JNK INHIBITOR AND CYCLOSPORIN
MXPA05013824A (en) 5-membered heterocycle-based p38 kinase inhibitors.
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
PT1635824E (en) 5-membered heterocycle-based p-38 inhibitors
TW200630090A (en) Triazoles useful as inhibitors of protein kinases
MX2009008290A (en) Antiperspirant / deodorant compositions.
TW200724140A (en) Hydantoin compounds
IL153147A0 (en) Phospholipid derivatives of valporic acid and mixtures thereof
SG131759A1 (en) Lubricating compositions for friction material interfaces
MY154783A (en) Oral care composition containing a mixed tocopherol component
WO2004052294A3 (en) Compositions and methods related to lipid:emodin formulations
BR0304218A (en) alicylic esters with musk fragrance
TW200504199A (en) Method of preventing lipids constituting lipid membrane from degradation and use thereof
MXPA05010416A (en) ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING omega3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF.
SE0201566D0 (en) New composition
MD2231C2 (en) Composition for treatment of oncologic pathologies
DE602004019500D1 (en) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees